multimodal techniques diagnosis prognosis alzheimers disease 
alzheimers disease affects millions people around world currently treatments prevent slow disease like neurodegenerative diseases alzheimers disease characterized protein misfolding brain process associated brain damage begin years substantial neurodegeneration accompanies dementia studies using new neuroimaging techniques fluid biomarkers suggest alzheimers disease pathology can detected preclinically advances allow design new clinical trials early mechanism-based therapeutic intervention 
